These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9532573)

  • 1. Degenerative and inherited neurological disorders.
    Lowenstein PR
    Mol Cell Biol Hum Dis Ser; 1995; 5():307-49. PubMed ID: 9532573
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gene and gene cellular therapy and neurodegenerative diseases].
    Ugriumov MV; Ermakov AS; Popov AP; Zhdanov RI
    Vopr Med Khim; 2000; 46(3):311-23. PubMed ID: 11033889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacology of neurodegenerative diseases: perspectives on cellular and gene therapies].
    Finiels F
    Therapie; 1998; 53(1):31-4. PubMed ID: 9773097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic gene therapy for a neurodegenerative disease using microencapsulated recombinant cells.
    Ross CJ; Ralph M; Chang PL
    Exp Neurol; 2000 Dec; 166(2):276-86. PubMed ID: 11085893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer therapy for neurodegenerative disorders.
    Feigin A; Eidelberg D
    Mov Disord; 2007 Jul; 22(9):1223-8; quiz 1369. PubMed ID: 17393533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
    Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
    Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
    Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
    Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell therapy for neurological disorders: a comprehensive review.
    Raedt R; Boon P
    Acta Neurol Belg; 2005 Sep; 105(3):158-70. PubMed ID: 16255154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can endogenous stem cells be stimulated to repair the degenerating brain?
    Michell AW; Phillips W; Barker RA
    J Pharm Pharmacol; 2004 Oct; 56(10):1201-10. PubMed ID: 15482633
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurosurgery for the 21st century. What does neurobiology justify for repairing neurodegenerative disorders?
    Sanberg PR; Willing AE; Cahill DW
    Clin Neurosurg; 2001; 48():113-26. PubMed ID: 11692635
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene therapy for neurodegenerative diseases based on lentiviral vectors.
    Nanou A; Azzouz M
    Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases.
    Wyman T; Rohrer D; Kirigiti P; Nichols H; Pilcher K; Nilaver G; Machida C
    Gene Ther; 1999 Oct; 6(10):1648-60. PubMed ID: 10516713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology insight: therapeutic RNA interference--how far from the neurology clinic?
    Gonzalez-Alegre P; Paulson HL
    Nat Clin Pract Neurol; 2007 Jul; 3(7):394-404. PubMed ID: 17611488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy: can neural stem cells deliver?
    Müller FJ; Snyder EY; Loring JF
    Nat Rev Neurosci; 2006 Jan; 7(1):75-84. PubMed ID: 16371952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cell cycle and human neurodegenerative disease.
    Vincent I; Pae CI; Hallows JL
    Prog Cell Cycle Res; 2003; 5():31-41. PubMed ID: 14593698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated virus-mediated gene delivery approaches for the treatment of CNS disorders.
    Terzi D; Zachariou V
    Biotechnol J; 2008 Dec; 3(12):1555-63. PubMed ID: 19072910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural stem cells and their use as therapeutic tool in neurological disorders.
    Pluchino S; Zanotti L; Deleidi M; Martino G
    Brain Res Brain Res Rev; 2005 Apr; 48(2):211-9. PubMed ID: 15850660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing polyglutamine degeneration with RNAi.
    Bonini NM; La Spada AR
    Neuron; 2005 Dec; 48(5):715-8. PubMed ID: 16337909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurogenesis and neurodegenerative diseases in human.
    Zhao B; Zhong M; Jin K
    Panminerva Med; 2008 Mar; 50(1):55-64. PubMed ID: 18427388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic strategies for neurodegenerative disorders: emerging clues from Parkinson's disease.
    Bjarkam CR; Sørensen JC
    Biol Psychiatry; 2004 Aug; 56(4):213-6. PubMed ID: 15312807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.